Non-Oil GDP Share: 76% ▲ -7.7pp vs 2020 | Saudi Unemployment: 3.5% ▲ -0.5pp vs 2023 | PIF AUM: $941.3B ▲ +$345B vs 2022 | Inbound FDI: $21.3B ▼ -6.4% vs 2023 | Female Participation: 33% ▲ -1.1pp vs 2023 | Credit Rating: Aa3/A+ ▲ Moody's / Fitch | GDP Growth: 2.0% ▲ +1.5pp vs 2023 | Umrah Pilgrims: 16.92M ▲ vs 11.3M target | Non-Oil GDP Share: 76% ▲ -7.7pp vs 2020 | Saudi Unemployment: 3.5% ▲ -0.5pp vs 2023 | PIF AUM: $941.3B ▲ +$345B vs 2022 | Inbound FDI: $21.3B ▼ -6.4% vs 2023 | Female Participation: 33% ▲ -1.1pp vs 2023 | Credit Rating: Aa3/A+ ▲ Moody's / Fitch | GDP Growth: 2.0% ▲ +1.5pp vs 2023 | Umrah Pilgrims: 16.92M ▲ vs 11.3M target |

This section examines Saudi Arabia’s healthcare sector, which is undergoing a structural transformation as Vision 2030 shifts the system toward privatisation, preventive care, and digital health innovation. Coverage includes hospital corporatisation under the Health Holding Company model, mandatory health insurance expansion, pharmaceutical manufacturing and biotech, mental health services, and the SEHA virtual hospital platform. Articles analyse regulatory developments by the Saudi Health Council and SFDA, public-private partnership frameworks, medical tourism ambitions, and workforce Saudisation targets. The section equips healthcare investors, providers, and policymakers with the data and analysis needed to navigate a sector projected to see sustained double-digit investment growth.